![Safety and Efficacy of Anlotinib, a Multikinase Angiogenesis Inhibitor, in Patients With Refractory Metastatic Soft Tissue Sarcoma]()
Safety and Efficacy of Anlotinib, a Multikinase Angiogenesis Inhibitor, in Patients With Refractory Metastatic Soft Tissue SarcomaChi, Yihebali; Fang, Zhiwei; Hong, Xiao-Nan; Yao, Yang; Sun, Ping; Wang, Guowen; Du, Feng; Sun, Yongkun; Wu, Qiong; Qu, Guofan; Wang, Shusen; Song, Jianmin; Yu, Jianchun; Lu, Yongkui; Zhu, Xia; Niu, Xiaohui; He, Zhiyong; Wang, Jinwan; Yu, Hao; Cai, Jianqiang · Clinical Cancer Research · 2018